Researchers in the United States and India have conducted a study demonstrating the real-world effectiveness of a single dose of Johnson & Johnson's Ad26.COV2.S vaccine at preventing infection with severe acute respiratory syndrome coronavirus 2 – the ...
from Google Alert - health https://ift.tt/3tkuKxk
via IFTTT
0 comments:
Post a Comment